Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (311-320 of 447) with videos related to

Pageof 45
Sort By:
Cell|November 16, 2019
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast CancerDaniel P Hollern, Nuo Xu, Aatish Thennavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerAranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.
Plos One|April 6, 2012
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinomaChad J Creighton, Anadulce Hernandez-Herrera, Anders Jacobsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II TrialAntonio Llombart-Cussac, Jose Pérez-García, Fara Brasó-Maristany, et al.
JAMA|June 8, 2006
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyLisa A Carey, Charles M Perou, Chad A Livasy, et al.
Cell Reports|August 9, 2018
Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland DevelopmentRajshekhar R Giraddi, Chi-Yeh Chung, Richard E Heinz, et al.
Cancer Research|May 31, 2018
FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationTuan M Nguyen, Elena B Kabotyanski, Yongchao Dou, et al.
Nature Communications|December 22, 2015
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3pChristina G Towers, Anna L Guarnieri, Doug S Micalizzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2026
Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapyCorinne H Strawser, Binita Chakraborty, Daniel Michaud, et al.
Clinical and Translational Medicine|October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systemsJulia E Altman, Amy L Olex, Emily K Zboril, et al.
Pageof 45

Showing results (311-320 of 447) with videos related to

Sort By:
Pageof 45
Cell|November 16, 2019
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast CancerDaniel P Hollern, Nuo Xu, Aatish Thennavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerAranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.
Plos One|April 6, 2012
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinomaChad J Creighton, Anadulce Hernandez-Herrera, Anders Jacobsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II TrialAntonio Llombart-Cussac, Jose Pérez-García, Fara Brasó-Maristany, et al.
JAMA|June 8, 2006
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyLisa A Carey, Charles M Perou, Chad A Livasy, et al.
Cell Reports|August 9, 2018
Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland DevelopmentRajshekhar R Giraddi, Chi-Yeh Chung, Richard E Heinz, et al.
Cancer Research|May 31, 2018
FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationTuan M Nguyen, Elena B Kabotyanski, Yongchao Dou, et al.
Nature Communications|December 22, 2015
The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3pChristina G Towers, Anna L Guarnieri, Doug S Micalizzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2026
Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapyCorinne H Strawser, Binita Chakraborty, Daniel Michaud, et al.
Clinical and Translational Medicine|October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systemsJulia E Altman, Amy L Olex, Emily K Zboril, et al.
Pageof 45